$SHOP Balance Sheet | Understand Stock

$SHOP

$168.18 -$0.50 (0.3%) Close

$SHOP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q4 FY2015 As of Dec 31, 2015
Assets
Current assets
Cash and cash equivalents
Marketable securities
Trade and other receivables, net
Loans and merchant cash advances, net
Income taxes receivable
Other current assets
Total current assets

Long-term assets
Property and equipment, net
Operating lease right-of-use assets, net
Equity and other investments
Intangible assets, net
Deferred tax assets
Other long-term assets
Long-term investments
Equity and other investments ($3,299 and $3,619, carried at fair value)
Equity method investment
Goodwill
Total long term assets

Total assets
Liabilities and shareholders’ equity
Current liabilities
Accounts payable and accrued liabilities
Current portion of deferred revenue
Income taxes payable
Deferred revenue
Current portion of lease incentives
Operating lease liabilities
Convertible senior notes
Total current liabilities

Long-term liabilities
Deferred revenue
Lease incentives
Deferred tax liability
Operating lease liabilities
Convertible senior notes
Deferred tax liabilities
Total long term liabilities

Equity, Attributable to Parent
Convertible preferred shares; nil and 27,159,277 shares authorized, issued and outstanding (aggregate liquidation preference of nil and $87,500)
Common stock, unlimited Class A subordinate voting shares authorized, 1,211,133,003 and 1,225,830,706, issued and outstanding; unlimited Class B restricted voting shares authorized, 78,073,584 and 78,073,594 issued and outstanding; 1 Founder Share authorized, 1 and 1 issued and outstanding
Additional paid-in capital
Accumulated other comprehensive (loss) income
Accumulated surplus
Total shareholders’ equity

Total liabilities and shareholders’ equity
Common shares issued (in shares)
Common shares outstanding (in shares)

Comments